Maud Tastevin
Overview
Explore the profile of Maud Tastevin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Korchia T, Faugere M, Tastevin M, Quaranta S, Guilhaumou R, Blin O, et al.
Encephale
. 2024 Nov;
PMID: 39547922
Introduction: Genetic polymorphisms in genes encoding enzymes metabolizing psychotropics drugs result in various isoenzymes with different catalytic efficacies. Of particular interest, some of these isoenzymes are highly catalytic leading to...
2.
Carrier-Auclair J, Lavoie M, Tastevin M, Laforce Jr R
Dement Geriatr Cogn Disord
. 2024 Sep;
54(1):40-51.
PMID: 39255780
Introduction: For over 25 years, cholinesterase inhibitors (ChEIs) have been the main symptomatic treatment for Alzheimer's disease (AD). Several meta-analyses have supported their effectiveness in various neurocognitive, functional, and behavioral...
3.
Korchia T, Tastevin M, Sunhary De Verville P, Joober R, Andrieu-Haller C, Faugere M, et al.
World J Biol Psychiatry
. 2022 Jan;
23(9):703-714.
PMID: 35057713
Background: In people with schizophrenia, major areas of everyday life are impaired, including independent living, productive activities, social relationships and overall quality of life. Enhanced understanding of factors that hinder...
4.
de la Sablonniere J, Tastevin M, Lavoie M, Laforce Jr R
Brain Sci
. 2021 Sep;
11(9).
PMID: 34573229
Primary progressive aphasias (PPAs) are a group of neurodegenerative diseases presenting with insidious and relentless language impairment. Three main PPA variants have been described: the non-fluent/agrammatic variant (nfvPPA), the semantic...
5.
Tastevin M, Lavoie M, de la Sablonniere J, Carrier-Auclair J, Laforce Jr R
Brain Sci
. 2021 Sep;
11(9).
PMID: 34573135
Knowledge on the natural history of the three main variants of primary progressive aphasia (PPA) is lacking, particularly regarding mortality. Moreover, advanced stages and end of life issues are rarely...
6.
Tastevin M, Boyer L, Korchia T, Fond G, Lancon C, Richieri R, et al.
EJNMMI Res
. 2020 Oct;
10(1):121.
PMID: 33030615
Background: Brain SPECT perfusion and PET metabolism have been, most often interchangeably, proposed to study the underlying pathological process in major depressive disorder (MDD). The objective of this study was...
7.
Tastevin M, Richieri R, Boyer L, Fond G, Lancon C, Guedj E
Brain Stimul
. 2020 Apr;
13(3):683-685.
PMID: 32289697
No abstract available.
8.
Tastevin M, Baumstarck K, Groppi F, Cermolacce M, Lagrange G, Lancon C, et al.
Brain Stimul
. 2019 Oct;
13(1):256-258.
PMID: 31564628
No abstract available.
9.
Tastevin M, Spatola G, Regis J, Lancon C, Richieri R
Neuropsychiatr Dis Treat
. 2019 Jun;
15:1259-1272.
PMID: 31190832
Deep brain stimulation (DBS) is a neuro-psychosurgical technique widely accepted in movement disorders, such as Parkinson's disease. Since 1999, DBS has been explored for severe, chronic and treatment-refractory psychiatric diseases....